When Leen Ezzeddine stood before her classmates at Harvard Medical School, the moment could have been framed as a familiar story of immigrant success: a Lebanese woman graduating as a doctor from one of the world’s most prestigious institutions.
But Ezzeddine chose to tell a different story.
In her graduation speech last week, she spoke of circumstance, borders, luck and the thin line separating her life from the lives of medical students in Lebanon and Palestine who share the same ambition but are made to study under drones, bombardment and displacement.
That line, for her, was not abstract. While she was pursuing her studies at Harvard, a US missile launched by Israel levelled her family home in Arab Salim, her mother’s village in southern Lebanon, in October 2024.
It was the village where she used to spend her summers, surrounded by cousins, relatives, and her grandparents, Hayat Chamseddine and Ali Zayour, who were later forced to leave and relocate to Beirut after their house was destroyed.
The contrast was stark: she was standing in Harvard as a new doctor, while the village that helped shape her childhood and family memories was being attacked.
That contradiction became the emotional and political centre of her intervention.
Her speech was not only about Gaza, or Lebanon, or the violence of war. It was about what it means to become a doctor inside an elite institution while entire communities are being denied the basic conditions of life.




Journalists may no longer enter the Pentagon’s press office, which has been designated as a classified space amid growing moves to restrict press access to the defense department.
The latest wave of anxiety followed a statement by Israeli Defence Minister Israel Katz, who warned that there would be “no calm in Beirut” if Hezbollah’s attacks on Israeli forces and northern Israel continued.
A team of UN experts has issued a “stark warning about surging Israeli settler terror” in the occupied West Bank and east Jerusalem and “the existential risk it poses to Palestinian communities’ presence on the land”.
A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least 30% in six of the world’s most common forms of the disease, early trial results show.
Iran says it's suspending talks with U.S. if Israel does not halt its expanding offensive in Lebanon





























